Cash flow Otsuka Corporation

Equities

4768

JP3188200004

IT Services & Consulting

Market Closed - Japan Exchange Other stock markets 06:30:00 12/02/2026 GMT			5-day change	1st Jan Change
3,096.00 ^JPY	-0.90%		+4.72%	-4.21%

02-04	Biodexa announces exclusive license of Otsuka's OPB-171775, a potent phase 1 ready molecular glue for GIST	RE
02-04	HBM Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2025	CI

3a0de71139aa4e.LQ8FL2Jq93kzmL6tOcQxiXe1HR1VnAdlYNicPmpuyyM.VEFVHyQ6gRABzfrUQPNA1kDzLVEf8TBRBqn-SFo3p2JMa21XDkewAEr66w

Published financial data: OTSUKA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	836B	852B	861B	977B	1,108B
Total Revenues	836B	852B	861B	977B	1,108B
Cost of Goods Sold, Total	663B	675B	677B	773B	883B
Gross Profit	174B	177B	184B	204B	224B
Selling General & Admin Expenses, Total	111B	115B	123B	135B	143B
Provision for Bad Debts	40M	-5M	89M	98M	394M
Depreciation & Amortization - (IS)	5.99B	6.15B	6.3B	6.26B	6.49B
Other Operating Expenses, Total	117B	121B	129B	141B	150B
Operating Income	56.32B	55.83B	54.77B	62.96B	74.22B
Interest Expense, Total	-44M	-44M	-43M	-41M	-55M
Interest And Investment Income	191M	239M	270M	398M	483M
Net Interest Expenses	147M	195M	227M	357M	428M
Income (Loss) On Equity Invest.	390M	794M	661M	825M	862M
Currency Exchange Gains (Loss)	118M	64M	335M	362M	696M
Other Non Operating Income (Expenses)	578M	679M	642M	13M	-273M
EBT, Excl. Unusual Items	57.55B	57.56B	56.64B	64.52B	75.93B
Gain (Loss) On Sale Of Investments	225M	19M	596M	-71M	-1.91B
Gain (Loss) On Sale Of Assets	-	886M	460M	707M	-
Asset Writedown	-189M	-276M	-1.18B	-271M	-179M
Other Unusual Items	-2M	-6M	-	10M	-
EBT, Incl. Unusual Items	57.58B	58.19B	56.51B	64.89B	73.84B
Income Tax Expense	17.77B	17.72B	16B	16.8B	19.61B
Earnings From Continuing Operations	39.81B	40.47B	40.51B	48.09B	54.22B
Net Income to Company	39.81B	40.47B	40.51B	48.09B	54.22B
Minority Interest	-500M	-543M	-488M	-640M	-744M
Net Income - (IS)	39.31B	39.93B	40.02B	47.45B	53.48B
Net Income to Common Incl Extra Items	39.31B	39.93B	40.02B	47.45B	53.48B
Net Income to Common Excl. Extra Items	39.31B	39.93B	40.02B	47.45B	53.48B
Per Share Items
Net EPS - Basic	103.66	105.29	105.54	125.13	141.04
Basic EPS - Continuing Operations	103.66	105.29	105.54	125.13	141.04
Basic Weighted Average Shares Outstanding	379M	379M	379M	379M	379M
Net EPS - Diluted	103.66	105.29	105.54	125.13	141.04
Diluted EPS - Continuing Operations	103.66	105.29	105.54	125.13	141.04
Diluted Weighted Average Shares Outstanding	379M	379M	379M	379M	379M
Normalized Basic EPS	93.53	93.45	92.06	104.65	123.19
Normalized Diluted EPS	93.53	93.45	92.06	104.65	123.19
Dividend Per Share	57.5	57.5	62.5	67.5	75
Payout Ratio	53.03	54.59	56.85	49.93	47.86
Supplemental Items
EBITDA	63.92B	63.82B	63.06B	70.89B	82.65B
EBITA	56.32B	55.83B	54.77B	62.96B	74.22B
EBIT	56.32B	55.83B	54.77B	62.96B	74.22B
EBITDAR	71.01B	71.29B	71.16B	78.88B	91.21B
Effective Tax Rate - (Ratio)	30.87	30.45	28.31	25.89	26.56
Total Current Taxes	17.79B	17.14B	16.84B	-	21.28B
Total Deferred Taxes	-12M	576M	-842M	-	-1.66B
Normalized Net Income	35.47B	35.44B	34.91B	39.68B	46.71B
Non-Cash Pension Expense	408M	-687M	-368M	-193M	-225M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	28.73B	-
General and Administrative Expenses	646M	605M	604M	578M	625M
Research And Development Expense From Footnotes	789M	1.04B	1.2B	1.57B	2.26B
Net Rental Expense, Total	7.1B	7.48B	8.1B	7.98B	8.56B
Imputed Operating Lease Interest Expense	282M	297M	322M	333M	479M
Imputed Operating Lease Depreciation	6.81B	7.18B	7.78B	7.65B	8.08B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	178B	205B	202B	229B	228B
Short Term Investments	40M	40M	40M	-	40M
Total Cash And Short Term Investments	178B	205B	202B	229B	228B
Accounts Receivable, Total	145B	136B	152B	155B	201B
Total Receivables	145B	136B	152B	155B	201B
Inventory	44.2B	35.03B	44.83B	38.24B	74.42B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	24.32B	25.6B	35.67B	37.69B	65.48B
Total Current Assets	392B	401B	435B	460B	569B
Gross Property Plant And Equipment	87.58B	84.39B	84.16B	-	83.3B
Accumulated Depreciation	-51.35B	-46.68B	-48.32B	-	-48.39B
Net Property Plant And Equipment	36.23B	37.71B	35.84B	34.67B	34.91B
Long-term Investments	16.9B	22.37B	22.68B	40.8B	22.82B
Other Intangibles, Total	15.13B	15.83B	15.77B	16.06B	20.28B
Deferred Tax Assets Long-Term	7.09B	5.34B	9.69B	10.47B	12.24B
Other Long-Term Assets, Total	4.43B	3.98B	3.93B	2M	14.8B
Total Assets	471B	486B	523B	562B	674B
Liabilities
Accounts Payable, Total	96.44B	91.94B	99.52B	125B	162B
Accrued Expenses, Total	3.84B	3.81B	3.88B	4.48B	5.26B
Short-term Borrowings	4.8B	4.8B	4.4B	4.4B	4.3B
Current Portion of Long-Term Debt	-	-	1.7B	-	-
Current Portion of Leases	875M	865M	927M	-	666M
Current Income Taxes Payable	9.37B	8.77B	9.08B	9.5B	13.79B
Unearned Revenue Current, Total	-	-	16.14B	-	17.76B
Other Current Liabilities	61.52B	60.1B	55.04B	59.57B	85.65B
Total Current Liabilities	177B	170B	191B	203B	290B
Long-Term Debt	1.7B	1.7B	-	1.7B	1.7B
Long-Term Leases	1.52B	1.48B	1.41B	1.2B	861M
Pension & Other Post Retirement Benefits	10.1B	9.91B	7.08B	7.6B	5.31B
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	1.1B	1.11B	1.11B	1.08B	1.1B
Total Liabilities	191B	184B	200B	215B	299B
Common Stock, Total	10.37B	10.37B	10.37B	10.37B	10.37B
Additional Paid In Capital	16.25B	16.25B	16.25B	16.25B	16.25B
Retained Earnings	255B	273B	289B	312B	339B
Treasury Stock	-139M	-139M	-140M	-141M	-143M
Comprehensive Income and Other	-4.14B	-581M	4.24B	5.09B	4.89B
Total Common Equity	277B	299B	319B	343B	371B
Minority Interest	2.69B	3.03B	3.34B	3.84B	4.45B
Total Equity	280B	302B	323B	347B	375B
Total Liabilities And Equity	471B	486B	523B	562B	674B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	379M	379M	379M	379M	379M
ECS Total Common Shares Outstanding	379M	379M	379M	379M	379M
Book Value / Share	731.39	787.82	842.26	904.83	977.83
Tangible Book Value	262B	283B	304B	327B	351B
Tangible Book Value Per Share	691.49	746.07	800.67	862.46	924.35
Total Debt	8.89B	8.85B	8.44B	7.3B	7.53B
Net Debt	-169B	-196B	-194B	-221B	-221B
Debt Equivalent of Unfunded Proj. Benefit Obligation	9.34B	9.21B	6.36B	6.96B	4.7B
Debt Equivalent Oper. Leases	56.76B	59.8B	64.78B	63.88B	68.48B
Minority Interest, Total (Incl. Fin. Div)	2.69B	3.03B	3.34B	3.84B	4.45B
Account Code - Inventory Valuation	6	6	6	-	6
Inventories - Raw Materials, Total	776M	740M	759M	755M	815M
Inventories - Work In Process, Total	1.41B	1.24B	1.44B	1.41B	1.67B
Inventories - Finished Goods, Total	42.01B	33.05B	42.64B	36.07B	71.94B
Land - (BS)	15.34B	15.09B	14.8B	-	14.45B
Buildings, Total	59.18B	52.83B	52.88B	-	50.42B
Full Time Employees	9.12K	9.17K	9.21K	9.42K	9.68K
Accumulated Allowance for Doubtful Accounts (Supple)	100M	75M	83M	93M	147M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	39.31B	39.93B	40.02B	64.89B	53.48B
Depreciation & Amortization - CF	7.6B	7.98B	8.29B	7.93B	8.43B
Depreciation & Amortization, Total	7.6B	7.98B	8.29B	7.93B	8.43B
(Gain) Loss From Sale Of Asset	46M	-823M	-395M	-436M	94M
(Gain) Loss on Sale of Investments - (CF)	-225M	-19M	-596M	74M	1.91B
Asset Writedown & Restructuring Costs	143M	220M	1.12B	-	85M
(Income) Loss On Equity Investments - (CF)	-390M	-794M	-661M	-825M	-862M
Other Operating Activities, Total	-3.04B	679M	160M	-16.93B	1.8B
Change In Accounts Receivable	4.56B	9.34B	-23.81B	-2.88B	-45.84B
Change In Inventories	-9.65B	9.17B	-9.72B	6.6B	-36.18B
Change In Accounts Payable	-5.85B	-5.42B	14.78B	6.36B	54.48B
Change in Other Net Operating Assets	-4M	-2.39B	-4M	6.86B	307M
Cash from Operations	32.5B	57.87B	29.2B	71.65B	37.71B
Capital Expenditure	-2.97B	-5.2B	-1.25B	-3.99B	-3.22B
Sale of Property, Plant, and Equipment	-	1.55B	969M	1.67B	-
Sale (Purchase) of Intangible assets	-5.89B	-5.68B	-5.83B	-6.36B	-8.87B
Investment in Marketable and Equity Securities, Total	124M	-160M	-1.96B	-12.28B	-8M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-150M	-	-
Other Investing Activities, Total	23M	336M	-133M	-521M	145M
Cash from Investing	-8.72B	-9.16B	-8.36B	-21.47B	-11.95B
Long-Term Debt Issued, Total	-	-	-	1.7B	-
Total Debt Issued	-	-	-	1.7B	-
Short Term Debt Repaid, Total	-	-	-400M	-	-100M
Long-Term Debt Repaid, Total	-	-	-	-1.7B	-
Total Debt Repaid	-	-	-400M	-1.7B	-100M
Common Dividends Paid	-20.85B	-21.8B	-22.75B	-23.69B	-25.6B
Common & Preferred Stock Dividends Paid	-20.85B	-21.8B	-22.75B	-23.69B	-25.6B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-141M	-160M	-154M	-148M	-196M
Cash from Financing	-20.99B	-21.96B	-23.31B	-23.84B	-25.89B
Foreign Exchange Rate Adjustments	-1M	2M	-4M	3M	1M
Miscellaneous Cash Flow Adjustments	-2M	-	-2M	-	1M
Net Change in Cash	2.79B	26.76B	-2.47B	26.34B	-127M
Supplemental Items
Cash Interest Paid	44M	44M	43M	39M	55M
Cash Income Tax Paid (Refund)	21.47B	17.8B	16.58B	17.26B	17.18B
Levered Free Cash Flow	18.09B	42.54B	17.97B	53.84B	19.84B
Unlevered Free Cash Flow	18.12B	42.57B	17.99B	53.87B	19.87B
Change In Net Working Capital	15.82B	-10.57B	17.45B	-16.93B	22.86B
Net Debt Issued / Repaid	-	-	-400M	0	-100M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.54	7.29	6.78	7.25	7.51
Return on Total Capital	12.58	11.64	10.67	11.48	12.57
Return On Equity %	14.7	13.91	12.97	14.36	15.02
Return on Common Equity	14.65	13.86	12.95	14.32	14.98
Margin Analysis
Gross Profit Margin %	20.77	20.76	21.39	20.87	20.27
SG&A Margin	13.32	13.49	14.29	13.78	12.94
EBITDA Margin %	7.64	7.49	7.32	7.25	7.46
EBITA Margin %	6.73	6.55	6.36	6.44	6.7
EBIT Margin %	6.73	6.55	6.36	6.44	6.7
Income From Continuing Operations Margin %	4.76	4.75	4.7	4.92	4.9
Net Income Margin %	4.7	4.69	4.65	4.85	4.83
Net Avail. For Common Margin %	4.7	4.69	4.65	4.85	4.83
Normalized Net Income Margin	4.24	4.16	4.05	4.06	4.22
Levered Free Cash Flow Margin	2.16	4.99	2.09	5.51	1.79
Unlevered Free Cash Flow Margin	2.17	5	2.09	5.51	1.79
Asset Turnover
Asset Turnover	1.79	1.78	1.71	1.8	1.79
Fixed Assets Turnover	23.17	23.04	23.41	27.72	31.84
Receivables Turnover (Average Receivables)	5.68	6.07	5.98	6.36	6.22
Inventory Turnover (Average Inventory)	16.83	17.04	16.95	18.62	15.68
Short Term Liquidity
Current Ratio	2.21	2.36	2.28	2.26	1.96
Quick Ratio	1.83	2	1.86	1.89	1.48
Operating Cash Flow to Current Liabilities	0.18	0.34	0.15	0.35	0.13
Days Sales Outstanding (Average Receivables)	64.42	60.12	61.05	57.42	58.81
Days Outstanding Inventory (Average Inventory)	21.75	21.42	21.53	19.6	23.34
Average Days Payable Outstanding	54.02	51.63	50.89	53.51	53.3
Cash Conversion Cycle (Average Days)	32.14	29.91	31.7	23.51	28.86
Long Term Solvency
Total Debt/Equity	3.18	2.93	2.62	2.11	2.01
Total Debt / Total Capital	3.08	2.85	2.55	2.06	1.97
LT Debt/Equity	1.15	1.06	0.44	0.84	0.68
Long-Term Debt / Total Capital	1.11	1.03	0.43	0.82	0.67
Total Liabilities / Total Assets	40.58	37.94	38.29	38.24	44.32
EBIT / Interest Expense	1.28K	1.27K	1.27K	1.54K	1.35K
EBITDA / Interest Expense	1.45K	1.45K	1.47K	1.73K	1.5K
(EBITDA - Capex) / Interest Expense	1.39K	1.33K	1.44K	1.63K	1.44K
Total Debt / EBITDA	0.14	0.14	0.13	0.1	0.09
Net Debt / EBITDA	-2.65	-3.07	-3.07	-3.12	-2.67
Total Debt / (EBITDA - Capex)	0.15	0.15	0.14	0.11	0.09
Net Debt / (EBITDA - Capex)	-2.78	-3.34	-3.14	-3.31	-2.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.66	1.86	1.07	13.51	13.33
Gross Profit, 1 Yr. Growth %	-3.49	1.82	4.11	10.76	10.05
EBITDA, 1 Yr. Growth %	-7.93	-0.16	-1.18	12.42	16.58
EBITA, 1 Yr. Growth %	-9.46	-0.86	-1.9	14.95	17.87
EBIT, 1 Yr. Growth %	-9.46	-0.86	-1.9	14.95	17.87
Earnings From Cont. Operations, 1 Yr. Growth %	-9.45	1.66	0.1	18.71	12.76
Net Income, 1 Yr. Growth %	-9.63	1.57	0.24	18.55	12.71
Normalized Net Income, 1 Yr. Growth %	-9.87	-0.09	-1.48	13.67	17.72
Diluted EPS Before Extra, 1 Yr. Growth %	-9.63	1.57	0.24	18.56	12.71
Accounts Receivable, 1 Yr. Growth %	-3.03	-6.36	12.24	1.87	29.4
Inventory, 1 Yr. Growth %	27.94	-20.75	27.99	-14.71	94.63
Net Property, Plant and Equip., 1 Yr. Growth %	0.79	4.09	-4.97	-3.24	0.69
Total Assets, 1 Yr. Growth %	2.05	3.17	7.56	7.42	19.95
Tangible Book Value, 1 Yr. Growth %	7.11	7.89	7.32	7.72	7.18
Common Equity, 1 Yr. Growth %	6.95	7.71	6.91	7.43	8.07
Cash From Operations, 1 Yr. Growth %	-33.36	78.09	-49.55	145.41	-47.37
Capital Expenditures, 1 Yr. Growth %	38.01	75.19	-75.99	219.46	-19.37
Levered Free Cash Flow, 1 Yr. Growth %	-53.6	135.15	-57.77	199.69	-62.54
Unlevered Free Cash Flow, 1 Yr. Growth %	-53.56	134.95	-57.73	199.39	-62.49
Dividend Per Share, 1 Yr. Growth %	4.55	0	8.7	8	11.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.91	-1.97	1.47	7.11	13.42
Gross Profit, 2 Yr. CAGR %	4.92	-0.87	2.96	7.38	10.4
EBITDA, 2 Yr. CAGR %	8.3	-4.13	-0.67	5.4	14.48
EBITA, 2 Yr. CAGR %	8.25	-5.25	-1.38	6.19	16.41
EBIT, 2 Yr. CAGR %	8.25	-5.25	-1.38	6.19	16.41
Earnings From Cont. Operations, 2 Yr. CAGR %	8.24	-4.05	0.88	9.01	15.7
Net Income, 2 Yr. CAGR %	8.16	-4.19	0.9	9.01	15.6
Normalized Net Income, 2 Yr. CAGR %	7.97	-5.11	-0.79	5.82	15.68
Diluted EPS Before Extra, 2 Yr. CAGR %	8.16	-4.19	0.9	9.01	15.6
Accounts Receivable, 2 Yr. CAGR %	4.69	-4.71	2.52	6.93	14.82
Inventory, 2 Yr. CAGR %	26.76	0.7	0.71	4.48	28.84
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.55	2.42	-0.55	-4.11	-1.3
Total Assets, 2 Yr. CAGR %	7.64	2.61	5.34	7.49	13.51
Tangible Book Value, 2 Yr. CAGR %	10.2	7.5	7.61	7.52	7.45
Common Equity, 2 Yr. CAGR %	9.88	7.33	7.31	7.17	7.75
Cash From Operations, 2 Yr. CAGR %	-8.3	8.94	-5.21	11.27	13.65
Capital Expenditures, 2 Yr. CAGR %	10.42	55.49	-35.15	-12.43	60.49
Levered Free Cash Flow, 2 Yr. CAGR %	-17.09	4.46	-0.34	12.5	5.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	-17.07	4.45	-0.35	12.49	5.1
Dividend Per Share, 2 Yr. CAGR %	16.32	2.25	4.26	8.35	9.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.56	3.88	-0.97	5.33	9.15
Gross Profit, 3 Yr. CAGR %	5.06	3.88	0.77	5.5	8.26
EBITDA, 3 Yr. CAGR %	8.15	5.4	-3.15	3.51	9
EBITA, 3 Yr. CAGR %	8.25	5.12	-4.15	3.79	9.95
EBIT, 3 Yr. CAGR %	8.25	5.12	-4.15	3.79	9.95
Earnings From Cont. Operations, 3 Yr. CAGR %	7.66	6	-2.69	6.5	10.24
Net Income, 3 Yr. CAGR %	7.59	5.92	-2.74	6.47	10.23
Normalized Net Income, 3 Yr. CAGR %	8.11	5.21	-3.91	3.81	9.65
Diluted EPS Before Extra, 3 Yr. CAGR %	7.59	5.92	-2.74	6.47	10.23
Accounts Receivable, 3 Yr. CAGR %	5.9	0.87	0.64	2.3	13.95
Inventory, 3 Yr. CAGR %	18.44	8.39	9.08	-4.71	28.56
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.24	0.97	-0.1	-1.45	-2.54
Total Assets, 3 Yr. CAGR %	7.41	6.13	4.24	6.03	11.49
Tangible Book Value, 3 Yr. CAGR %	9.32	9.42	7.44	7.64	7.4
Common Equity, 3 Yr. CAGR %	9.22	9.15	7.19	7.35	7.47
Cash From Operations, 3 Yr. CAGR %	-3.49	14.41	-15.72	30.15	-13.3
Capital Expenditures, 3 Yr. CAGR %	26.25	28.78	-16.59	10.34	-14.81
Levered Free Cash Flow, 3 Yr. CAGR %	-12.31	17.36	-22.76	43.84	-22.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.3	17.35	-22.74	43.79	-22.42
Dividend Per Share, 3 Yr. CAGR %	18	10.6	4.35	5.49	9.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.55	5.77	4.49	5.16	4.55
Gross Profit, 5 Yr. CAGR %	5.32	4.78	4.21	5.27	4.51
EBITDA, 5 Yr. CAGR %	8.21	6.92	4.53	5.4	3.55
EBITA, 5 Yr. CAGR %	8.58	7.06	4.29	5.55	3.6
EBIT, 5 Yr. CAGR %	8.58	7.06	4.29	5.55	3.6
Earnings From Cont. Operations, 5 Yr. CAGR %	10.76	8.52	4.89	7.19	4.29
Net Income, 5 Yr. CAGR %	10.64	8.4	4.87	7.15	4.22
Normalized Net Income, 5 Yr. CAGR %	8.38	6.99	4.46	5.46	3.49
Diluted EPS Before Extra, 5 Yr. CAGR %	10.64	8.4	4.87	7.15	4.22
Accounts Receivable, 5 Yr. CAGR %	6.67	4.32	4.54	3.25	6.08
Inventory, 5 Yr. CAGR %	16.02	5.63	11.01	6.81	16.59
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.5	-0.74	-0.96	-1.09	-0.58
Total Assets, 5 Yr. CAGR %	7.73	7.18	6.58	6.67	7.85
Tangible Book Value, 5 Yr. CAGR %	9.89	9.64	8.63	8.66	7.44
Common Equity, 5 Yr. CAGR %	9.87	9.49	8.45	8.35	7.41
Cash From Operations, 5 Yr. CAGR %	3.3	19.32	-4.18	13.14	-5.01
Capital Expenditures, 5 Yr. CAGR %	14.82	29.82	-3.28	10.37	8.37
Levered Free Cash Flow, 5 Yr. CAGR %	-	22.11	-7.71	15.39	-12.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	22.07	-7.7	15.38	-12.62
Dividend Per Share, 5 Yr. CAGR %	18.13	15.9	12.3	9.69	6.4